Ep0216 611
Ep0216 611
Manchester, United Kingdom1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder. | Epilepsy, Generalized, Epileptic Syndromes, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Spasms, Infantile, brain disorder, central nervous system disorder, epilepsy, epilepsy with generalized tonic-clonic seizures, nervous system disorder, visual epilepsy | Active, not recruiting | Phase 3 | 2026-04-29 | NCT05064878 |